Advisory Committees

An Internal Advisory Committee will be charged with monitoring the progress of the PJIs, selecting new PJIs for second phase participation, and advising the PI on COBRE development. Many committee members are past or current COBRE PIs. The duties of the Internal Advisory Committee include:

• Meet with PJls, review their progress reports, and provide comments for the PJls' projects every quarter.
• Review all grant proposals from the PJls and provide feedback for the grant proposals.
• Monitor all Core services to ensure the effectiveness of the Core operations.
• Follow the academic growth of PJls and set the milestones for PJls.
• Nominate and select new PJI candidates and search for new candidates to recruit to OU Health Sciences Center.
• Advise the PI in the selection of new PJI candidates and the search for new candidates to recruit to OU Health Sciences Center.
• Advise the PI concerning the COBRE operation and policy.

Members

Joseph J. Ferretti, PhD
Former OUHSC Provost
Professor, Microbiology & Immunology
OUHSC, Oklahoma City, OK

James Tomasek, PhD
Vice President for Research
OUHSC, Oklahoma City, OK

John J. Iandolo, PhD
Vice President for Research (Retired)
OUHSC, Oklahoma City, OK

Judith A. James, MD, PhD
Member and Program Chair
Arthritis & Clinical Immunology Program
Oklahoma Medical Research Foundation, Oklahoma City, OK

Rodger P. McEver, MD
Member and Program Chair
Cardiovascular Biology Research Program
Oklahoma Medical Research Foundation, Oklahoma City, OK

Robert E. Anderson, MD, PhD
Director of Research
Dean A. McGee Eye Institute, Oklahoma City, OK

Jian-Xing Ma, MD, PhD
Chair, Department of Physiology
College of Medicine
OUHSC, Oklahoma City, OK

Darrin R. Akins, PhD
Associate Dean for Research
College of Medicine
OUHSC, Oklahoma City, OK

External Advisory Committee

An External Advisory Committee, consisting of five nationally recognized cancer scientists, will meet with the PI, the Internal Advisory Committee, and the PJIs twice a year, monitoring the progress of their projects as well as the overall progress of the COBRE.

These researchers will meet with the COBRE investigators twice per year: once in the fall in Oklahoma and once in the spring during the annual meeting of the American Association for Cancer Research.

The proposed External Advisory Committee of the COBRE will have the following responsibilities:

• Critique the scientific progress of the COBRE, including the investigator projects and the core modules.
• Interact one-on-one with PJIs and provide guidance and recommendations.
• Monitor and critique the COBRE policy and operation, including selecting PJI and milestones for progress.
• Monitor the Core services and utilization.
• Review applications and assist in the selection of new investigators who request funding in subsequent years. The selections will then be forwarded by the PI to NIH for further review and approval.
• Provide advice and direction to the PI and IAC regarding all aspects of the program.
• Critique the performance of the PI.
• The EAC will prepare a written report at the fall meeting. Minutes will be recorded at the spring meeting. Both will be available for review by NIH program staff.

Members

Channing J. Der, PhD
Professor, Department of Pharmacology Director, NIH Cancer Cell Biology Training
Lineberger Comprehensive Cancer Center
University of North Carolina, Chapel Hill, NC

J. Silvio Gutkind, PhD
Chief, Oral and Pharyngeal Cancer Branch
NIDCR
National Institutes of Health

Jennifer Grandis, MD
Program Leader, Head & Neck Cancer Program
University of Pittsburgh Cancer Institute

Gordon Mills, MD, PhD
Professor of Medicine, Olga Keith Wiess Distinguished University Chair for Cancer Research
Chair, Department of Systems Biology
Head, Kleberg Center for Molecular Markers
M.D. Anderson Cancer Center, Houston, TX

Premkumar Reddy, PhD
Professor and Director Experimental Therapeutics Institute
Mount Sinai School of Medicine, NY